PDCD1 and neoplasm: In mice treated with SGT-53, either alone or in combination with anti-PD-1, an IHC analysis revealed a significant inhibition of tumor cell proliferation as indicated by the loss of Ki-67 expression compared to tumors in untreated mice or those treated with anti-PD-1 alone (Figure 1D,E).